CLDN1 is highly expressed in hepatocellular carcinoma and acts as a promoter of epithelial-to-mesenchymal transition (EMT) through the c-Abl-Ras-Raf-1-ERK1/2 signaling axis (22, 69, 70). The gene discussed is CLDN1; the disease is hepatocellular carcinoma.